The dual behavior of PCSK9 in the regulation of apoptosis is crucial in Alzheimer's disease progression (Review)

By                  

Biomedical Reports, Vol. 2, Iss. 2, 2014-01 ,pp. : 167-171

Spandidos Publications

Access to resources Recommend Favorite

Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies

By Ciccarelli Giovanni   D’Elia Saverio   De Paulis Michele   Golino Paolo   Cimmino Giovanni  

Diseases, Vol. 6, Iss. 1, 2018-03 ,pp. : 22-22

MDPI

Access to resources Recommend Favorite

Non-Native Conformational Isomers of the Catalytic Domain of PCSK9 Induce an Immune Response, Reduce Lipids and Increase LDL Receptor Levels

By Jiang Chuantao   Nischal Hersharan   Sun Hua   Li Li   Cao Ying   Wei Peng   Chang Jui-Yoa   Teng Ba-Bie  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-02 ,pp. : 640-640

MDPI

Access to resources Recommend Favorite

Edaravone (Radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke (Review)

By Kikuchi  

Biomedical Reports, Vol. 1, Iss. 1, 2013-01 ,pp. : 7-12

Spandidos Publications

Access to resources Recommend Favorite

TNF-α Blocker Effect of Naringenin-Loaded Sericin Microparticles that Are Potentially Useful in the Treatment of Psoriasis

By Chlapanidas Theodora   Perteghella Sara   Leoni Flavio   Faragò Silvio   Marazzi Mario   Rossi Daniela   Martino Emanuela   Gaggeri Raffaella   Collina Simona  

International Journal of Molecular Sciences, Vol. 15, Iss. 8, 2014-08 ,pp. : 13624-13636

MDPI

Access to resources Recommend Favorite